Profile data is unavailable for this security.
About the company
ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.
- Revenue in USD (TTM)8.05m
- Net income in USD-9.02m
- Incorporated2008
- Employees31.00
- LocationReShape Lifesciences Inc1001 CALLE AMANECERSAN CLEMENTE 92673United StatesUSA
- Phone+1 (949) 429-6680
- Fax+1 (302) 636-5454
- Websitehttps://www.reshapelifesciences.com/obalon/
Mergers & acquisitions
Acquired company | RSLS:NAQ since announced | Transaction value |
---|---|---|
Vyome Therapeutics Inc | -56.24% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Arch Therapeutics Inc | 148.17k | -12.99m | 1.42m | 8.00 | -- | -- | -- | 9.60 | -3.69 | -3.69 | 0.0383 | -2.83 | 0.10 | 0.0662 | -- | 18,521.25 | -828.03 | -188.28 | -- | -804.63 | 39.58 | -- | -8,276.08 | -26,945.92 | 0.0051 | -1.32 | -- | -- | 383.83 | -- | -32.35 | -- | -21.76 | -- |
NanoVibronix Inc | 3.37m | -2.82m | 1.53m | 10.00 | -- | 0.539 | -- | 0.454 | -1.32 | -1.32 | 1.50 | 1.02 | 0.7081 | 0.431 | 12.05 | 337,300.00 | -59.12 | -116.16 | -122.41 | -169.36 | 64.57 | 50.47 | -83.49 | -570.47 | 1.16 | -14.77 | 0.00 | -- | 203.59 | 48.33 | 31.88 | -- | -34.02 | -- |
Helius Medical Technologies Inc | 594.00k | -8.84m | 1.54m | 22.00 | -- | 0.2432 | -- | 2.60 | -10.68 | -10.68 | 0.5042 | 1.98 | 0.0606 | 0.7486 | 4.48 | 27,000.00 | -90.17 | -98.37 | -110.33 | -143.57 | 12.79 | 37.27 | -1,487.54 | -1,580.66 | 3.80 | -- | 0.00 | -- | -18.17 | 6.14 | 37.11 | -- | -41.95 | -- |
Tivic Health Systems Inc | 1.11m | -6.75m | 1.61m | 9.00 | -- | 0.3852 | -- | 1.45 | -4.33 | -4.33 | 0.5469 | 0.6779 | 0.2373 | 0.9156 | 76.76 | 123,666.70 | -143.94 | -- | -176.98 | -- | 27.85 | -- | -606.47 | -- | 6.59 | -- | 0.00 | -- | -36.09 | -- | 18.34 | -- | -- | -- |
Leafbuyer Technologies Inc | 5.43m | -959.15k | 2.00m | 14.00 | -- | -- | -- | 0.3687 | -0.0096 | -0.0096 | 0.0545 | -0.0179 | 3.64 | -- | 41.85 | 387,721.40 | -64.23 | -62.47 | -- | -- | 35.23 | 33.53 | -17.67 | -62.40 | -- | -6.34 | -- | -- | 33.72 | 35.17 | -161.23 | -- | -- | -- |
Avinger Inc | 7.43m | -15.34m | 2.11m | 68.00 | -- | 0.2267 | -- | 0.2834 | -12.13 | -12.13 | 5.83 | 4.05 | 0.434 | 1.23 | 8.03 | 109,250.00 | -113.20 | -70.93 | -1,387.68 | -131.57 | 19.96 | 30.87 | -260.86 | -208.91 | 1.20 | -11.66 | 0.3428 | -- | -7.51 | -0.6736 | 32.76 | -- | -24.21 | -- |
Tenon Medical Inc | 3.37m | -13.87m | 2.13m | 21.00 | -- | -- | -- | 0.6319 | -39.79 | -39.79 | 9.45 | 1.76 | 0.4252 | 2.27 | 5.27 | 160,571.40 | -174.87 | -- | -495.99 | -- | 60.32 | -- | -411.27 | -- | 1.02 | -- | 0.00 | -- | 323.73 | -- | 17.63 | -- | -- | -- |
Nuwellis Inc | 9.01m | -22.81m | 2.30m | 59.00 | -- | -- | -- | 0.2548 | -181.60 | -181.60 | 48.48 | -13.25 | 0.8292 | 1.52 | 7.30 | 152,779.70 | -192.57 | -98.07 | -301.19 | -122.48 | 60.28 | 55.22 | -232.24 | -230.51 | 0.7119 | -1.52 | -- | -- | 3.76 | 12.14 | -55.78 | -- | 4.61 | -- |
SINTX Technologies Inc | 3.13m | -8.60m | 2.35m | 43.00 | -- | 0.2656 | -- | 0.7506 | -271.52 | -271.52 | 16.44 | 11.82 | 0.1818 | 1.77 | 7.63 | 72,697.67 | -50.01 | -45.71 | -62.67 | -57.36 | 67.72 | 58.47 | -275.14 | -681.80 | 1.79 | -- | 0.0265 | -- | 68.29 | 94.24 | 49.75 | -- | 54.10 | -- |
Vycor Medical Inc | 1.36m | -506.30k | 2.53m | 8.00 | -- | -- | -- | 1.86 | -0.0155 | -0.0156 | 0.0417 | -0.1081 | 1.43 | 0.6694 | 5.08 | 170,011.30 | -19.13 | -47.86 | -- | -- | 89.23 | 89.60 | -13.38 | -35.42 | 0.0987 | -0.8001 | -- | -- | 19.43 | -0.6542 | 46.49 | -- | -31.77 | -- |
ReShape Lifesciences Inc | 8.05m | -9.02m | 2.54m | 31.00 | -- | 0.838 | -- | 0.3161 | -74.86 | -74.86 | 27.64 | 5.99 | 0.882 | 0.8035 | 4.79 | 259,548.40 | -98.88 | -136.06 | -169.55 | -194.32 | 67.47 | 56.30 | -112.11 | -408.36 | 0.8875 | -- | 0.00 | -- | -22.79 | -0.9474 | 75.36 | -- | -49.29 | -- |
Invo Bioscience Inc | 5.77m | -7.08m | 2.63m | 25.00 | -- | -- | -- | 0.4553 | -3.24 | -3.24 | 2.44 | 0.3529 | 0.4677 | 12.00 | 34.74 | 230,781.20 | -57.44 | -94.63 | -116.03 | -151.45 | 44.89 | 74.91 | -122.80 | -343.11 | 0.2686 | -4.75 | 0.6588 | -- | 267.38 | 43.62 | 26.24 | -- | 87.09 | -- |
Acutus Medical Inc | 12.16m | -5.82m | 3.16m | 233.00 | -- | -- | -- | 0.2596 | -0.1965 | 0.6966 | 0.413 | -0.1639 | 0.1791 | 1.32 | 1.44 | 52,184.55 | -8.58 | -46.76 | -11.07 | -56.88 | -13.40 | -89.12 | -47.89 | -773.49 | 1.88 | -3.39 | 1.18 | -- | 136.36 | 27.03 | -141.35 | -- | -35.99 | -- |
Venus Concept Inc | 69.81m | -49.93m | 3.19m | 304.00 | -- | 0.8623 | -- | 0.0457 | -8.38 | -8.38 | 11.92 | 0.5103 | 0.751 | 1.03 | 2.25 | 229,634.90 | -53.53 | -32.71 | -82.19 | -44.01 | 68.39 | 68.16 | -71.28 | -48.50 | 1.30 | -2.75 | 0.9133 | -- | -23.26 | 28.31 | 14.76 | -- | -35.08 | -- |
Fuse Medical Inc | 18.40m | 3.63m | 3.33m | 31.00 | 1.25 | -- | 0.9016 | 0.1807 | 0.036 | 0.036 | 0.2307 | -0.0031 | 0.9593 | 0.7018 | 5.75 | 593,671.90 | 18.91 | 0.7504 | 48.45 | 1.35 | 64.95 | 54.98 | 19.72 | 0.6552 | 0.3143 | -1.13 | 1.12 | -- | -8.67 | -6.72 | 295.11 | 34.66 | -- | -- |
Holder | Shares | % Held |
---|---|---|
Gesalcal� SA SGIICas of 30 Jun 2024 | 325.54k | 1.39% |
Geode Capital Management LLCas of 30 Jun 2024 | 132.57k | 0.57% |
Virtu Americas LLCas of 30 Jun 2024 | 58.91k | 0.25% |
The Vanguard Group, Inc.as of 31 Mar 2024 | 49.87k | 0.21% |
Tower Research Capital LLCas of 31 Mar 2024 | 49.57k | 0.21% |
BlackRock Fund Advisorsas of 31 Mar 2024 | 34.06k | 0.15% |
Millennium Management LLCas of 31 Mar 2024 | 29.79k | 0.13% |
Goldman Sachs & Co. LLC (Private Banking)as of 31 Mar 2024 | 23.04k | 0.10% |
Jane Street Capital LLCas of 31 Mar 2024 | 22.93k | 0.10% |
SSgA Funds Management, Inc.as of 31 Mar 2024 | 13.02k | 0.06% |